🌸 Transdermal vs Oral Estrogen Delivery Simulator

Oral Estrogen and Hepatic First-Pass Metabolism

Swallowed estrogen is absorbed in the gut and routed directly to the liver.

• Gut: Absorption site (Placeholder fact only)
• High: First pass (Placeholder fact only)
• Elevated: Hepatic exposure (Placeholder fact only)
• Reduced: Bioavailability (Placeholder fact only)

Gut-to-liver pathway

Placeholder text describing oral absorption and portal circulation.

Transdermal Delivery Bypasses Hepatic First-Pass

Skin patches or gels deliver estrogen directly into systemic circulation.

• Skin: Absorption site (Placeholder fact only)
• Bypassed: First pass (Placeholder fact only)
• Minimal: Hepatic exposure (Placeholder fact only)
• Higher: Bioavailability (Placeholder fact only)

Skin-to-blood pathway

Placeholder text describing transdermal absorption route.

Clotting Factor Synthesis Differs by Route

Hepatic exposure changes production of procoagulant proteins.

• Increased: Oral clotting shift (Placeholder fact only)
• Minimal: Transdermal shift (Placeholder fact only)
• Route-dependent: Fibrinogen effect (Placeholder fact only)
• Route-dependent: Protein C/S effect (Placeholder fact only)

Liver-driven coagulation proteins

Placeholder text on clotting factor synthesis differences.

Venous Thromboembolism Risk by Delivery Route

Oral estrogen carries higher VTE risk than transdermal in studies.

• Higher: Oral VTE risk (Placeholder fact only)
• Lower: Transdermal VTE risk (Placeholder fact only)
• Route-dependent: Relative risk (Placeholder fact only)
• Observational: Evidence base (Placeholder fact only)

Comparative VTE incidence

Placeholder text summarizing VTE risk comparison studies.

Choosing a Route Based on Risk Factors

Patient-specific risk factors should guide the delivery route choice.

• Favor transdermal: High-risk patients (Placeholder fact only)
• Either route: Low-risk patients (Placeholder fact only)
• Obesity, smoking, clotting history: Key risk factors (Placeholder fact only)
• Individualized: Clinical guidance (Placeholder fact only)

Personalizing the delivery decision

Placeholder text on individualized route selection.

Placeholder highlight callout on route selection guidance.